Gemtuzumab ozogamicin with donor leucocyte infusions is safe and effective therapy for a subgroup of relapsed acute myeloid leukaemia and myelodysplastic syndrome following allogeneic haemopoietic stem cell transplantation (HSCT)

K Raj; M Aldouri; A Ho; A Pagliuca; S Devereux; G Mufti

Gemtuzumab ozogamicin with donor leucocyte infusions is safe and effective therapy for a subgroup of relapsed acute myeloid leukaemia and myelodysplastic syndrome following allogeneic haemopoietic stem cell transplantation (HSCT)

K Raj, M Aldouri, A Ho, A Pagliuca, S Devereux, G Mufti

King's College London

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	500A - 500A
Journal	Blood
Volume	104
Issue number	11
Publication status	Published - 2004
Event	46th Annual Meeting of the American-Society-of-Hematology - San Diego, CA Duration: 4 Dec 2004 → 7 Dec 2004

Cite this

@article{891a402013c84cf782a8c246049bad23,

title = "Gemtuzumab ozogamicin with donor leucocyte infusions is safe and effective therapy for a subgroup of relapsed acute myeloid leukaemia and myelodysplastic syndrome following allogeneic haemopoietic stem cell transplantation (HSCT)",

author = "K Raj and M Aldouri and A Ho and A Pagliuca and S Devereux and G Mufti",

year = "2004",

language = "English",

volume = "104",

pages = "500A -- 500A",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "11",

note = "46th Annual Meeting of the American-Society-of-Hematology ; Conference date: 04-12-2004 Through 07-12-2004",

}

Gemtuzumab ozogamicin with donor leucocyte infusions is safe and effective therapy for a subgroup of relapsed acute myeloid leukaemia and myelodysplastic syndrome following allogeneic haemopoietic stem cell transplantation (HSCT). / Raj, K; Aldouri, M; Ho, A et al.
In: Blood, Vol. 104, No. 11, 2004, p. 500A - 500A.

Research output: Contribution to journal › Meeting abstract

TY - JOUR

T1 - Gemtuzumab ozogamicin with donor leucocyte infusions is safe and effective therapy for a subgroup of relapsed acute myeloid leukaemia and myelodysplastic syndrome following allogeneic haemopoietic stem cell transplantation (HSCT)

AU - Raj, K

AU - Aldouri, M

AU - Ho, A

AU - Pagliuca, A

AU - Devereux, S

AU - Mufti, G

PY - 2004

Y1 - 2004

M3 - Meeting abstract

SN - 1528-0020

VL - 104

SP - 500A - 500A

JO - Blood

JF - Blood

IS - 11

T2 - 46th Annual Meeting of the American-Society-of-Hematology

Y2 - 4 December 2004 through 7 December 2004

ER -